Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care (PrevenUP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01595347
Recruitment Status : Unknown
Verified January 2012 by Francisco Javier Navarro Moya, Andaluz Health Service.
Recruitment status was:  Enrolling by invitation
First Posted : May 10, 2012
Last Update Posted : May 10, 2012
Sponsor:
Information provided by (Responsible Party):
Francisco Javier Navarro Moya, Andaluz Health Service

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Pressure ulcers (UPP) represent an important sanitary problem affecting mostly elderly immobilized persons, increasing the burden of care to professionals in the health system, as well as pharmaceutical spending. There are studies of the effectiveness of various products in the prevention of the UPP, most made in hospitals and using fundamentally composed based on oily hyperbecome oxygenated acids (AGHO).

There do not exist studies realized specifically with cream of olive oil.

AIMS:

Principal: To verify the efficiency of a new intervention of UPP's prevention in immobilized patients consisting in the application of cream of olive oil. Secondary: To evaluate the cost - efficiency of this new intervention opposite to AGHO's application.

To value the degree of satisfaction of the patient and his keeper with regard to the use of cream of olive oil.

METHODOLOGY DESIGN: clinical Test randomized with two parallel branches. AREA: Population consultant of the health centers in the province of Malaga. SUBJECTS OF STUDY: Patients immobilized at the risk of developing UPP. INTERVENTION: Administration of cream of olive oil to the group of intervention and AGHO's administration to the group control. Follow-up for one year. VARIABLES. Principal variable: UPP's appearance. Secondary: Demographic and clinical data, presence of technical supports, information of the caragiver and questionnaire of satisfaction. STATISTICAL ANALYSIS: Test. Exact of Fischer. Odds's calculation ratio. Shapiro-Wilk's test. Parametric test t- student or test U of Mann-Whitney. Reason of the increase cost efficiency (ICER). Logistic regression model multivariant.


Condition or disease Intervention/treatment Phase
Pressure Ulcer Drug: Hyper-oxigenated fatty acid Other: Olive oil's cream Phase 4

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 410 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary Care.A Cluster Randomized Clinical Trial.
Study Start Date : January 2012
Estimated Primary Completion Date : September 2013
Estimated Study Completion Date : January 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pressure Sores
Drug Information available for: Olive oil

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Active Comparator: Hyper-oxigenated fatty acid
Hyper-oxigenated fatty acid,Equisetum arvense, Hypericum perforatum
 Drug: Hyper-oxigenated fatty acid
Aplicación tópica de Mepentol (R) en zonas de riesgo de úlceras por presión (sacro, caderas y talones) 1 aplicación/24 horas
Experimental: Olive oil's Cream
Cream with 60% extra virgin olive oil.
 Other: Olive oil's cream
Application Olive oil's cream to 60% in areas at risk of pressure ulcers (sacrum, hips and heels) 1 application / 24 hours


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Appearance grade II pressure ulcers [ Time Frame: 48 months ]
    The primary outcome or result is the appearance of grade II pressure ulcers in patients under study during the 9 months follow up. This will be confirmed by observation of the areas where we did the intervention (sacrum, hips and heels).


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Patients with nursing diagnosis "risk of impaired skin integrity. "To determine this risk assessment tool we will use as the Braden scale. We will include only patients immobilized with increased risk of pressure ulcers (score less than or equal to 16).
  • Patients with malnutrition or suspected malnutrition. To determine this state as an instrument we will use Mini Nutritional Assessment Scale "MNA" (score 10 points or less)
  • Over 18 years.

Exclusion criteria:

  • Patients refusal to participate in the study.
  • Moved (patient no habitual residence in the health center where they make the study).
  • Patients with plans to be out of the study area during the monitoring year.
  • Hospitalized during the uptake phase of the sample
  • Patient-terminal.
  • Patient with the presence of pressure ulcers.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01595347


Locations
Layout table for location information
Spain
Distrito Sanitario Málaga. Servicio Andaluz de Salud
Málaga, Spain, 29009
Sponsors and Collaborators
Andaluz Health Service
Investigators
Layout table for investigator information
Study Chair: Inmaculada Lupiáñez-Pérez, Enfermera Distrito Sanitario Málaga. Servicio Andaluz de Salud
Principal Investigator: Leovigildo Ginel-Mendoza, Medico Distrito Sanitario Málaga. Servicio Andaluz de Salud
Principal Investigator: Francisco Javier Navarro-Moya, Enfermero Distrito Sanitario Málaga. Servicio Andaluz de Salud
Principal Investigator: Francisco Javier Martín-Santos, Enfermero Distrito Sanitario Málaga. Servicio Andaluz de Salud
Principal Investigator: Rafaela Sepúlveda-Guerra, Enfermera Distrito Sanitario Málaga. Servicio Andaluz de Salud
Principal Investigator: Rosa Vázquez-Cerdeiros, Enfermera Distrito Sanitario Málaga. Servicio Andaluz de Salud
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Francisco Javier Navarro Moya, Effectiveness and Research Unit Coordinator. Distrito Sanitario Málaga., Andaluz Health Service
ClinicalTrials.gov Identifier: NCT01595347    
Other Study ID Numbers: DSM-SAS-2012-1
First Posted: May 10, 2012    Key Record Dates
Last Update Posted: May 10, 2012
Last Verified: January 2012
Keywords provided by Francisco Javier Navarro Moya, Andaluz Health Service:
Pressure Ulcer
Primary Prevention
Fatty Acids
 Vegetable Fats
Olive oil
"Pressure Ulcer[prevention and control]"[Mesh]
Additional relevant MeSH terms:
Layout table for MeSH terms
Pressure Ulcer
Ulcer
Pathologic Processes
Skin Ulcer
Skin Diseases